Medical Updates

Survival Outcomes with Pembrolizumab in Patients with Advanced Urothelial Carcinoma

A Japanese retrospective real-life study highlighted the favourable cancer control outcomes with pembrolizumab in patients with advanced urothelial...

17 Jan, 2020

Email this page
Safety and Efficacy of Mirabegron in the Treatment of Overactive Bladder Symptoms

Pooled analysis of 10 mirabegron monotherapy studies demonstrated the safety and efficacy of mirabegron, solifenacin, and tolterodine in adults of...

13 Jan, 2020

Email this page
Better Outcomes with Three-Dimensional Augmented Reality Robot-Partial Nephrectomy in Management of Complex Renal Tumours

A recent study concluded that three-dimensional hyperaccuracy models (HA3D) models could help the surgeons to effectively perform augmented reality...

09 Jan, 2020

Email this page
Comparative Analysis of Pharmacotherapy for OAB Symptoms

Although antimuscarinic drugs and the beta 3 agonist mirabegron have been the mainstay of therapy for overactive bladder (OAB), there is lack of...

31 Oct, 2019

Email this page

Key Trials

No Significant Changes in Lipid and Glucose Metabolism with Degarelix and Leuprolide Treatment in Prostate Cancer

There were no significant differences in the lipid and glucose metabolism in the patients of prostate cancer treated with degarelix and leuprolide...

Superior Long-Term Clinical Outcomes with HoLEP as Compared to TURP in the Treatment of Benign Prostate Hyperplasia

In patients with small to mid-sized prostates, holmium laser enucleation of the prostate (HoLEP) was associated with longer operation time, less...

Daily Tadalafil More Effective than On-Demand Tadalafil in Long-Term Treatment of Erectile Dysfunction

Tadalafil daily was associated with better efficacy than on-demand tadalafil in men with erectile dysfunction after at least 24 weeks of treatment....

Addition of Docetaxel to Androgen Deprivation Therapy Improves Survival Outcomes and is Cost-Effective in Metastatic Prostate Cancer

The survival outcomes associated with addition of docetaxel to androgen deprivation therapy (Doc-ADT) were superior compared to maximum androgen-...

Slide Library

Tadalafil (Tadaflo)

Erectile dysfunction (ED) and the signs and symptoms of benign prostatic hyperplasia (BPH), are prevalent disorders in middle-aged and older men...

Email this page
Cranberry + D-mannose (Cranfit)

Around 50% of women experience at least one episode of UTI at some point in their lifetime and recurrent UTI occur in about 20-40% of women....

Email this page
Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

Email this page
Solifenacin succinate (Soliact)

The overall prevalence of overactive bladder (OAB) in men and women over the age of 40 years is 16.6%. Anticholinergic therapy is currently a...

Email this page

Our Publications

Update on Urolithiasis: Evaluation of Relation between Renal Papillary Abnormalities with Stone Composition and Description into a New Classification by Flexible Ureteroscopy

This update on urolithiasis described the incidence of papillary abnormalities in patients undergoing flexible ureteroscopy and its relation with...

Update on Urolithiasis: Evaluation of the Association of Obesity with Perioperative Outcomes following PCNL in Patients with Kidney Stones

This update on urolithiasis evaluated the association of obesity with adverse outcomes following percutaneous nephrolithotomy.

UTI: Physician Update

Physician update (issue 3) takes you through the recent news & information related to Urinary Tract Infections (UTI) followed by the various...

Role of Pyridoxine in Management of Urolithiasis

This literature provides information on role of pyridoxine in prevention of recurrence of calcium oxalate stones.

Patient Education

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also,...


Explore >>

Currently there is no content under this category.


Which testosterone preparation do you prefer in your patients with late onset hypogonadism?
Testosterone Cypionate/Enanthate
14% (1 vote)
Testosterone undecanoate injection
43% (3 votes)
Testosterone decanoate + testosterone isocaproate + testosterone phenpropionate + testosterone propionate injection
14% (1 vote)
Oral testosterone undecanoate
29% (2 votes)
Testosterone gel
0% (0 votes)
Total votes: 7